Harnessing the Immune System to Tackle Small Cell Lung Cancer

Immunotherapy has improved first-line therapy for small cell lung cancer and has activity in the relapsed setting as well. The immunobiology of small cell lung cancer poses challenges for immunotherapy, and efforts are underway to unlock to the potential of immunotherapy through the identification o...

Full description

Saved in:
Bibliographic Details
Published inThe cancer journal (Sudbury, Mass.) Vol. 26; no. 6; p. 502
Main Authors Newton, Benjamin Robert, Chiang, Anne C
Format Journal Article
LanguageEnglish
Published United States 01.11.2020
Online AccessGet more information

Cover

More Information
Summary:Immunotherapy has improved first-line therapy for small cell lung cancer and has activity in the relapsed setting as well. The immunobiology of small cell lung cancer poses challenges for immunotherapy, and efforts are underway to unlock to the potential of immunotherapy through the identification of meaningful disease subsets and the development of novel combination therapies.
ISSN:1540-336X
DOI:10.1097/PPO.0000000000000490